Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Aug 8, 2019 · 10-Q · 39 days after period end · 0001564590-19-030879
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$3.62M | -$2.79M | -$169.00K | -$238.00K |
| EPS Diluted | -$10.08 | -$1.82 | -$79.60 | -$11.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 8, 2019 · 39 d after period end
